Press News

Press News

Press News | 10.12.2025

Print:
Title Media Publ. Date
Public sector arrears have exceeded €3.8 billion Kathimerin 10/12/2025
Greece accounts for 12% of pharmaceutical production in the EU Ta Nea 10/12/2025

 

See here the publicity

 

Web Monitoring Report for the period 09/12 – 10/12

Title Media Publ. Date
Who is eligible for the free obesity medicines and will receive the SMS? capital.gr 10/12/2025
Georgiadis on the cancellation of oncology appointments: Farmers should not destroy their fellow citizens cnn.gr 10/12/2025
ELSTAT survey: 70.9% of patients in the country receive care in public hospitals healthdaily.gr 09/12/2025
Concern about the adequate availability of high-dose influenza vaccines iatronet.gr 10/12/2025
“proSfEEroume” in Lamia: Pharmaceutical and medical supplies distributed to schools and church institutions iatropedia.gr 09/12/2025
The NHS at a breaking point – What led to the weakening of the public healthcare system in.gr 10/12/2025
EOPYY: Pharmacist remanded for issuing thousands of fake prescriptions in.gr 09/12/2025
Joint Press Conference on “Personal Health Assistant for Citizens” moh.gov.gr 10/12/2025
Kyriakos Mitsotakis: The investment clawback will continue even after the Recovery Fund naftemporiki.gr 09/12/2025
Adonis Georgiadis on Naftemporiki TV: The major reform for high-cost medicines begins – There is not a single health indicator that has not improved naftemporiki.gr 09/12/2025
High-cost medicines in neighbourhood pharmacies – Which they are and how patients will receive them for free ygeiamou.gr 10/12/2025
In four facilities in Lamia, the social contribution of the Hellenic Red Cross and SFEE ygeiamou.gr 09/12/2025

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.